Cryoprecipitate & Fibrinogen Replacement: An ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Updated July 2026  |  More ICU nursing guides →

In a bleeding patient who has already received red cells and plasma, there is often one clotting protein that quietly runs out first: fibrinogen. It is the raw material the coagulation cascade turns into the actual clot, and when it falls too low, no amount of platelets or plasma will make a stable one. Cryoprecipitate — and, increasingly, fibrinogen concentrate — is how the team puts that raw material back. For the ICU nurse, cryo is a product with quirks worth knowing: it comes in small volumes, it has to be thawed and pooled, and it is easy to underestimate how fast fibrinogen disappears in massive hemorrhage, obstetric bleeding, and DIC.

What cryoprecipitate actually is

Cryoprecipitate is the cold-insoluble portion of plasma. When a unit of fresh frozen plasma is thawed slowly at refrigerator temperature, a small precipitate forms; that precipitate, refrozen, is cryo. It concentrates several clotting components into a very small volume — roughly 10 to 15 mL per unit — which is exactly why it is useful when you want to raise fibrinogen without giving a large fluid load.

Each single unit of cryo contains a defined minimum of fibrinogen (factor I), along with factor VIII, factor XIII, von Willebrand factor, and fibronectin. In practice cryo is used mainly to replace fibrinogen and factor XIII; the factor VIII and von Willebrand content matter historically but are now usually treated with specific concentrates when those are the problem.

When fibrinogen is the missing link

Fibrinogen is consumed and diluted faster than most other factors during heavy bleeding, and it is the first coagulation protein to reach a critical low in massive hemorrhage. Common ICU settings where cryo or fibrinogen concentrate is reached for include massive transfusion, obstetric hemorrhage (where fibrinogen falls dramatically and early), disseminated intravascular coagulation with a low fibrinogen level, trauma-induced coagulopathy, and liver failure with bleeding.

The usual trigger is a measured or suspected low fibrinogen. Many protocols aim to keep fibrinogen above roughly 1.5 to 2 g/L (150–200 mg/dL) in active major or obstetric bleeding, and above about 1.0 g/L in other bleeding, though exact thresholds vary by facility and by the point-of-care viscoelastic testing (TEG/ROTEM) some centers use to detect a low clot-strength contribution from fibrinogen in real time.

Dosing, thawing, and the practical steps

Cryo is usually dosed as a pool of several units — a common adult dose is one pool of about 5 units (or a "10-pack" in some systems), which raises fibrinogen by a modest, predictable amount. The blood bank thaws and, in many systems, pools the units; once thawed, cryo has a limited shelf life (commonly a few hours to 24 hours depending on whether it is pooled and how it is prepared), so it should be transfused promptly and not left sitting.

At the bedside the nurse verifies the product and patient with two identifiers per policy, uses a standard blood administration set with a filter, and infuses relatively quickly because the volume is small. Cryo does not require crossmatch for red cell antigens, but many facilities prefer ABO-compatible cryo when feasible because it contains plasma; large volumes of ABO-incompatible plasma-containing product can rarely cause hemolysis. Follow your blood bank's guidance on ABO selection for the specific patient.

Fibrinogen concentrate as an alternative

Many centers now stock a fibrinogen concentrate — a lyophilized, virally-inactivated product reconstituted at the bedside or in pharmacy. Its advantages are a standardized fibrinogen dose, no thawing delay, smaller volume, and no ABO matching. It is dosed in grams to a target fibrinogen level. Whether your unit uses cryo, concentrate, or both depends on local protocol; the nursing priorities — verify, infuse promptly, watch for reactions, recheck the level — are the same.

What the ICU nurse monitors

Draw a follow-up fibrinogen level after the dose (per protocol, often after the product has circulated) to confirm the target was reached, since ongoing bleeding may consume it as fast as you replace it. Watch for the general transfusion hazards that apply to any plasma-containing product: allergic and febrile reactions, and volume considerations, though cryo's small volume makes fluid overload less of a concern than with plasma. Keep the bigger picture in view — cryo is one lever within a balanced resuscitation, and it works best alongside surgical or obstetric source control, calcium repletion, warming, and correction of acidosis. Related critical-care guides: the massive transfusion protocol, disseminated intravascular coagulation, fresh frozen plasma, and tranexamic acid.